STARPHARMA HOLDINGS LIMITED - Announcements

0.00%

13.0¢

Market Cap $54.36M

Healthcare Biotechnology

Starpharma Holdings Limited is an Australia-based biotechnology company. The principal... Starpharma Holdings Limited is an Australia-based biotechnology company. The principal activities of the Company consist of research, development and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its portfolio of dendrimer-based products includes three clinical-stage DEP (dendrimer enhanced product) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over-the-counter (OTC) products. It has developed a pipeline of novel DEP oncology products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, it has a preclinical pipeline of DEP radiopharmaceuticals and DEP Antibody-Drug Conjugates (ADCs) in development. Its VIRALEZE Nasal Spray is a broad-spectrum nasal spray intended to provide a protective barrier in the nose that traps and blocks cold/respiratory viruses. It also offers VivaGel BV and VivaGel Condom products. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

SPL	Appendix 3B		26/11/10	74.25KB	Share
SPL	Response to an ASX Price Query	PRICE SENSITIVE	18/11/10	101.08KB	Share
SPL	Appendix 3B		17/11/10	71.46KB	Share
SPL	Results of Meeting		12/11/10	36.94KB	Share
SPL	AGM Chairman's address and CEO presentation		11/11/10	1012.86KB	Share
SPL	Appendix 3B		11/11/10	62.65KB	Share
SPL	Appendix 3B		10/11/10	63.26KB	Share
SPL	Starpharma's partner SSL acquired by Reckitt Benckiser	PRICE SENSITIVE	04/11/10	38.73KB	Share
SPL	Appendix 3B		03/11/10	65.03KB	Share
SPL	Appendix 3B		26/10/10	62.65KB	Share
SPL	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/10	60.38KB	Share
SPL	SPL presents at ASX Small to MidCaps conference in Hong Kong		20/10/10	1.43MB	Share
SPL	Appendix 3B		14/10/10	64.8KB	Share
SPL	Notice of Annual General Meeting/Proxy Form		07/10/10	518.89KB	Share
SPL	Lapse of Unquoted Share Options		07/10/10	24.79KB	Share
SPL	Shareholder Update October 2010		01/10/10	720.15KB	Share
SPL	Starpharma Expands Lilly Partnership	PRICE SENSITIVE	30/09/10	15.5KB	Share
SPL	Appendix 3B		27/09/10	70.94KB	Share
SPL	Appendix 3B		21/09/10	70.92KB	Share
SPL	Appendix 3B		09/09/10	64.76KB	Share
SPL	Appendix 3B		02/09/10	66.77KB	Share
SPL	Change in substantial holding		27/08/10	85.43KB	Share
SPL	Annual Report and full year financial results	PRICE SENSITIVE	25/08/10	1.25MB	Share
SPL	VivaGel condom patent grant extends coverage	PRICE SENSITIVE	18/08/10	25.97KB	Share
SPL	Employee Performance Rights Plan and Offers		17/08/10	30.37KB	Share
SPL	Starpharma announces Phase 2 BV study of VivaGel	PRICE SENSITIVE	16/08/10	25.73KB	Share
SPL	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/10	63.21KB	Share
SPL	SPL Partner SSL Announces Recommended Cash Offer		22/07/10	39.41KB	Share
SPL	Lapse of Unquoted Options		19/07/10	24.82KB	Share
SPL	Starpharma's Bacterial Vaginosis Study gets FDA Clearance	PRICE SENSITIVE	15/07/10	83.8KB	Share
SPL	Starpharma appoints further VP Business Development		12/07/10	23.13KB	Share
SPL	Expiry of options - change of director's interest notice		05/07/10	15.09KB	Share
SPL	Lapse of unquoted employee share options		05/07/10	25.41KB	Share
SPL	Change of Director's Interest Notice		01/07/10	14.52KB	Share
SPL	SPL and Monash University collaboration receives ARC grant	PRICE SENSITIVE	29/06/10	26.07KB	Share
SPL	Appendix 3B		24/06/10	64.71KB	Share
SPL	Change in substantial holding		22/06/10	81.55KB	Share
SPL	Change in substantial holding		18/06/10	81.66KB	Share
SPL	Change of Director's Interest Notice		15/06/10	14.31KB	Share
SPL	CEO Investor Presentation ASX Spotlight forum		20/05/10	851.18KB	Share
SPL	Shareholder Update May 2010		29/04/10	1.73MB	Share
SPL	Appendix 4C - quarterly	PRICE SENSITIVE	27/04/10	52.84KB	Share
SPL	Change of Director's Interest Notice		31/03/10	13.57KB	Share
SPL	Appendix 3B		31/03/10	67.38KB	Share
SPL	Results of Meeting		25/03/10	25.83KB	Share
SPL	Successful completion of VivaGel study sexually active women	PRICE SENSITIVE	12/03/10	39.69KB	Share
TSN +ACR ADU AED AEJ AEZ AIO AJA RCM AMU ATM AVG AVX AXM AZZ ASQ BCS BLY BUL CAA CAH BHM CCP CDI PRG CIX CMV COK COZ CPL CRE CSV CTO CUV CVC CWT CXC CXM DCG DKN DLS DML DOM EAU EPX FEA FGE FML FPG FRS GDO ETM GPM GWR GXY GZL HDI NGI HGO HIG HIN HTA IDT ILF IMD IOH ITO IVA KAM KMD KRL KRM LLA MAE AEV MCE MCP MDT MEL MFG MIN 5GN GG8 MMW MRE MSF MTU MYR MYS NAN NBS NEC DTZ NGE NGF NKP NOD KZA NVT OAK OEL SYN AKE PBP ATH PME PPI PRU PTN AX1 RCI RCT VAU REF RFE RRL RXM SAR SFC SFH SFR SGN SGT SLR SNO SPL SRV SSM SUL TAM TCQ TGA TOX TPM TZL UBI UNS VIR VMG VPE VRL VTA WDS WEC WTP WYL ZSP	SandP Announces March SP/ASX Index Rebalance		05/03/10	35.82KB	Share
SPL	Appendix 3B		25/02/10	63.23KB	Share
SPL	Notice of Extraordinary General Meeting/Proxy Form		22/02/10	1.12MB	Share
SPL	Half Yearly Report and Accounts	PRICE SENSITIVE	18/02/10	261.89KB	Share
SPL	Shareholder Update February 2010		11/02/10	278.75KB	Share
SPL	Appendix 3B		09/02/10	64.57KB	Share
SPL	Starpharma and Lilly Sign New Drug Delivery Collaboration	PRICE SENSITIVE	01/02/10	23.5KB	Share
SPL	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/10	42.9KB	Share
SPL	Appendix 3B		28/01/10	63.29KB	Share
SPL	Appendix 3B		21/01/10	64.82KB	Share
SPL	Lapse of Unquoted Options		05/01/10	25.04KB	Share
SPL	Becoming a substantial holder		24/11/09	81.39KB	Share
SPL	Cleansing Statement		24/11/09	29.64KB	Share
SPL	Appendix 3B		24/11/09	64.41KB	Share
SPL	Starpharma announces $15.6 million capital raising	PRICE SENSITIVE	18/11/09	27.69KB	Share
SPL	Reinstatement to Official Quotation	PRICE SENSITIVE	18/11/09	23.43KB	Share
SPL	Suspension from Official Quotation	PRICE SENSITIVE	16/11/09	47.25KB	Share
SPL	Results of Meeting		13/11/09	31.06KB	Share
SPL	AGM Chairman's and CEO's Presentations		12/11/09	655.46KB	Share
SPL	Trading Halt	PRICE SENSITIVE	12/11/09	39.97KB	Share
SPL	Starpharma signs agrochemicals deal	PRICE SENSITIVE	05/11/09	25.77KB	Share
SPL	New legislation results in withdrawal of CEO incentive schem		29/10/09	26.76KB	Share
SPL	Appendix 4C - quarterly	PRICE SENSITIVE	23/10/09	61.4KB	Share
SPL	Notice of Annual General Meeting/Proxy Form		12/10/09	881.67KB	Share
SPL	Annual Report to shareholders		30/09/09	1.31MB	Share
SPL	US Patent Grant Extends VivaGel Coverage to 2024	PRICE SENSITIVE	22/09/09	24.5KB	Share
SPL	Release of Shares From Escrow		18/09/09	15.96KB	Share
SPL	Shareholder Update		17/09/09	345.49KB	Share
SPL	Preliminary Final Report	PRICE SENSITIVE	24/08/09	509.96KB	Share
SPL	Interim Financial Results - Material Improvement	PRICE SENSITIVE	04/08/09	26.32KB	Share
SPL	VivaGel - Anti-HIV and Herpes Activity following human admin	PRICE SENSITIVE	03/08/09	46.88KB	Share
SPL	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/09	47.26KB	Share
SPL	Appendix 3B - Employee Share Options		30/06/09	65.81KB	Share
SPL	Lapse of unquoted options		30/06/09	25.24KB	Share
SPL	Shareholder Update June 2009		02/06/09	3.54MB	Share
SPL	Change in substantial holding		25/05/09	56.34KB	Share
SPL	Cleansing Statement		22/05/09	28.02KB	Share
SPL	Appendix 3B		22/05/09	64.82KB	Share
SPL	Appendix 3B		22/05/09	64.8KB	Share
SPL	Completes $7.1m capital raising	PRICE SENSITIVE	21/05/09	24.28KB	Share
SPL	CEO Investor Presentation		13/05/09	22.68KB	Share
SPL	Elanco deal triggers Starpharma SPP extension	PRICE SENSITIVE	11/05/09	21.71KB	Share
SPL	Starpharma and Elanco sign agreement	PRICE SENSITIVE	11/05/09	34.34KB	Share
SPL	Share Purchase Plan Extension		05/05/09	22.35KB	Share
SPL	Shareholder Update May 2009		30/04/09	333.37KB	Share
SPL	Share Purchase Plan		22/04/09	620.74KB	Share
SPL	Cleansing Statement		08/04/09	28.1KB	Share
SPL	Appendix 3B		08/04/09	64.51KB	Share
SPL	Appendix 4C - quarterly	PRICE SENSITIVE	07/04/09	45.6KB	Share
SPL	Raises additional capital via institutional placement	PRICE SENSITIVE	07/04/09	25.46KB	Share
SPL	Trading Halt Request		03/04/09	24.68KB	Share
SPL	Trading Halt	PRICE SENSITIVE	03/04/09	18.71KB	Share
SPL	Completes patient testing in retention of activity study	PRICE SENSITIVE	19/03/09	40.14KB	Share
SPL	Half Yearly Report and Accounts	PRICE SENSITIVE	19/02/09	227.84KB	Share

SPLAppendix 3B
26/11/10		74.25KB	Share
SPLResponse to an ASX Price Query
18/11/10	PRICE SENSITIVE	101.08KB	Share
SPLAppendix 3B
17/11/10		71.46KB	Share
SPLResults of Meeting
12/11/10		36.94KB	Share
SPLAGM Chairman's address and CEO presentation
11/11/10		1012.86KB	Share
SPLAppendix 3B
11/11/10		62.65KB	Share
SPLAppendix 3B
10/11/10		63.26KB	Share
SPLStarpharma's partner SSL acquired by Reckitt Benckiser
04/11/10	PRICE SENSITIVE	38.73KB	Share
SPLAppendix 3B
03/11/10		65.03KB	Share
SPLAppendix 3B
26/10/10		62.65KB	Share
SPLAppendix 4C - quarterly
25/10/10	PRICE SENSITIVE	60.38KB	Share
SPLSPL presents at ASX Small to MidCaps conference in Hong Kong
20/10/10		1.43MB	Share
SPLAppendix 3B
14/10/10		64.8KB	Share
SPLNotice of Annual General Meeting/Proxy Form
07/10/10		518.89KB	Share
SPLLapse of Unquoted Share Options
07/10/10		24.79KB	Share
SPLShareholder Update October 2010
01/10/10		720.15KB	Share
SPLStarpharma Expands Lilly Partnership
30/09/10	PRICE SENSITIVE	15.5KB	Share
SPLAppendix 3B
27/09/10		70.94KB	Share
SPLAppendix 3B
21/09/10		70.92KB	Share
SPLAppendix 3B
09/09/10		64.76KB	Share
SPLAppendix 3B
02/09/10		66.77KB	Share
SPLChange in substantial holding
27/08/10		85.43KB	Share
SPLAnnual Report and full year financial results
25/08/10	PRICE SENSITIVE	1.25MB	Share
SPLVivaGel condom patent grant extends coverage
18/08/10	PRICE SENSITIVE	25.97KB	Share
SPLEmployee Performance Rights Plan and Offers
17/08/10		30.37KB	Share
SPLStarpharma announces Phase 2 BV study of VivaGel
16/08/10	PRICE SENSITIVE	25.73KB	Share
SPLAppendix 4C - quarterly
27/07/10	PRICE SENSITIVE	63.21KB	Share
SPLSPL Partner SSL Announces Recommended Cash Offer
22/07/10		39.41KB	Share
SPLLapse of Unquoted Options
19/07/10		24.82KB	Share
SPLStarpharma's Bacterial Vaginosis Study gets FDA Clearance
15/07/10	PRICE SENSITIVE	83.8KB	Share
SPLStarpharma appoints further VP Business Development
12/07/10		23.13KB	Share
SPLExpiry of options - change of director's interest notice
05/07/10		15.09KB	Share
SPLLapse of unquoted employee share options
05/07/10		25.41KB	Share
SPLChange of Director's Interest Notice
01/07/10		14.52KB	Share
SPLSPL and Monash University collaboration receives ARC grant
29/06/10	PRICE SENSITIVE	26.07KB	Share
SPLAppendix 3B
24/06/10		64.71KB	Share
SPLChange in substantial holding
22/06/10		81.55KB	Share
SPLChange in substantial holding
18/06/10		81.66KB	Share
SPLChange of Director's Interest Notice
15/06/10		14.31KB	Share
SPLCEO Investor Presentation ASX Spotlight forum
20/05/10		851.18KB	Share
SPLShareholder Update May 2010
29/04/10		1.73MB	Share
SPLAppendix 4C - quarterly
27/04/10	PRICE SENSITIVE	52.84KB	Share
SPLChange of Director's Interest Notice
31/03/10		13.57KB	Share
SPLAppendix 3B
31/03/10		67.38KB	Share
SPLResults of Meeting
25/03/10		25.83KB	Share
SPLSuccessful completion of VivaGel study sexually active women
12/03/10	PRICE SENSITIVE	39.69KB	Share
TSN +ACR ADU AED AEJ AEZ AIO AJA RCM AMU ATM AVG AVX AXM AZZ ASQ BCS BLY BUL CAA CAH BHM CCP CDI PRG CIX CMV COK COZ CPL CRE CSV CTO CUV CVC CWT CXC CXM DCG DKN DLS DML DOM EAU EPX FEA FGE FML FPG FRS GDO ETM GPM GWR GXY GZL HDI NGI HGO HIG HIN HTA IDT ILF IMD IOH ITO IVA KAM KMD KRL KRM LLA MAE AEV MCE MCP MDT MEL MFG MIN 5GN GG8 MMW MRE MSF MTU MYR MYS NAN NBS NEC DTZ NGE NGF NKP NOD KZA NVT OAK OEL SYN AKE PBP ATH PME PPI PRU PTN AX1 RCI RCT VAU REF RFE RRL RXM SAR SFC SFH SFR SGN SGT SLR SNO SPL SRV SSM SUL TAM TCQ TGA TOX TPM TZL UBI UNS VIR VMG VPE VRL VTA WDS WEC WTP WYL ZSPSandP Announces March SP/ASX Index Rebalance
05/03/10		35.82KB	Share
SPLAppendix 3B
25/02/10		63.23KB	Share
SPLNotice of Extraordinary General Meeting/Proxy Form
22/02/10		1.12MB	Share
SPLHalf Yearly Report and Accounts
18/02/10	PRICE SENSITIVE	261.89KB	Share
SPLShareholder Update February 2010
11/02/10		278.75KB	Share
SPLAppendix 3B
09/02/10		64.57KB	Share
SPLStarpharma and Lilly Sign New Drug Delivery Collaboration
01/02/10	PRICE SENSITIVE	23.5KB	Share
SPLAppendix 4C - quarterly
29/01/10	PRICE SENSITIVE	42.9KB	Share
SPLAppendix 3B
28/01/10		63.29KB	Share
SPLAppendix 3B
21/01/10		64.82KB	Share
SPLLapse of Unquoted Options
05/01/10		25.04KB	Share
SPLBecoming a substantial holder
24/11/09		81.39KB	Share
SPLCleansing Statement
24/11/09		29.64KB	Share
SPLAppendix 3B
24/11/09		64.41KB	Share
SPLStarpharma announces $15.6 million capital raising
18/11/09	PRICE SENSITIVE	27.69KB	Share
SPLReinstatement to Official Quotation
18/11/09	PRICE SENSITIVE	23.43KB	Share
SPLSuspension from Official Quotation
16/11/09	PRICE SENSITIVE	47.25KB	Share
SPLResults of Meeting
13/11/09		31.06KB	Share
SPLAGM Chairman's and CEO's Presentations
12/11/09		655.46KB	Share
SPLTrading Halt
12/11/09	PRICE SENSITIVE	39.97KB	Share
SPLStarpharma signs agrochemicals deal
05/11/09	PRICE SENSITIVE	25.77KB	Share
SPLNew legislation results in withdrawal of CEO incentive schem
29/10/09		26.76KB	Share
SPLAppendix 4C - quarterly
23/10/09	PRICE SENSITIVE	61.4KB	Share
SPLNotice of Annual General Meeting/Proxy Form
12/10/09		881.67KB	Share
SPLAnnual Report to shareholders
30/09/09		1.31MB	Share
SPLUS Patent Grant Extends VivaGel Coverage to 2024
22/09/09	PRICE SENSITIVE	24.5KB	Share
SPLRelease of Shares From Escrow
18/09/09		15.96KB	Share
SPLShareholder Update
17/09/09		345.49KB	Share
SPLPreliminary Final Report
24/08/09	PRICE SENSITIVE	509.96KB	Share
SPLInterim Financial Results - Material Improvement
04/08/09	PRICE SENSITIVE	26.32KB	Share
SPLVivaGel - Anti-HIV and Herpes Activity following human admin
03/08/09	PRICE SENSITIVE	46.88KB	Share
SPLAppendix 4C - quarterly
27/07/09	PRICE SENSITIVE	47.26KB	Share
SPLAppendix 3B - Employee Share Options
30/06/09		65.81KB	Share
SPLLapse of unquoted options
30/06/09		25.24KB	Share
SPLShareholder Update June 2009
02/06/09		3.54MB	Share
SPLChange in substantial holding
25/05/09		56.34KB	Share
SPLCleansing Statement
22/05/09		28.02KB	Share
SPLAppendix 3B
22/05/09		64.82KB	Share
SPLAppendix 3B
22/05/09		64.8KB	Share
SPLCompletes $7.1m capital raising
21/05/09	PRICE SENSITIVE	24.28KB	Share
SPLCEO Investor Presentation
13/05/09		22.68KB	Share
SPLElanco deal triggers Starpharma SPP extension
11/05/09	PRICE SENSITIVE	21.71KB	Share
SPLStarpharma and Elanco sign agreement
11/05/09	PRICE SENSITIVE	34.34KB	Share
SPLShare Purchase Plan Extension
05/05/09		22.35KB	Share
SPLShareholder Update May 2009
30/04/09		333.37KB	Share
SPLShare Purchase Plan
22/04/09		620.74KB	Share
SPLCleansing Statement
08/04/09		28.1KB	Share
SPLAppendix 3B
08/04/09		64.51KB	Share
SPLAppendix 4C - quarterly
07/04/09	PRICE SENSITIVE	45.6KB	Share
SPLRaises additional capital via institutional placement
07/04/09	PRICE SENSITIVE	25.46KB	Share
SPLTrading Halt Request
03/04/09		24.68KB	Share
SPLTrading Halt
03/04/09	PRICE SENSITIVE	18.71KB	Share
SPLCompletes patient testing in retention of activity study
19/03/09	PRICE SENSITIVE	40.14KB	Share
SPLHalf Yearly Report and Accounts
19/02/09	PRICE SENSITIVE	227.84KB	Share

REFRESH

First 6 7 8 9 10

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 13.0¢		Change 0.000(0.00%)		Mkt cap ! $54.36M

Open	High	Low	Value	Volume
13.5¢	13.5¢	13.0¢	$66.89K	513.9K

Buyers (Bids)

No.	Vol.	Price($)
4	221560	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.5¢	224531	9

View Market Depth

No.	Vol.	Price($)
4	221560	0.125
3	120252	0.120
3	138350	0.115
2	9099	0.110
3	106433	0.105

Price($)	Vol.	No.
0.135	224531	9
0.140	155588	4
0.145	65835	6
0.150	175000	3
0.155	74523	3

Last trade - 13.53pm 08/09/2025 (20 minute delay)


Last 13.0¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
13.0¢	13.3¢	12.5¢	284444
Last updated 13.53pm 08/09/2025 ?

SPL (ASX) Chart

STARPHARMA HOLDINGS LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Clean energy vehicles with hydrogen production and distribution all under one roof

Prospect Resources continues to advance Mumbezhi project

Leeuwin Metals set to unlock significant gold potential at Marda

Haranga Resources: From uranium in Senegal to gold in the US

Top Stories

STARPHARMA HOLDINGS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Clean energy vehicles with hydrogen production and distribution all under one roof

Prospect Resources continues to advance Mumbezhi project

Leeuwin Metals set to unlock significant gold potential at Marda

Haranga Resources: From uranium in Senegal to gold in the US

Top Stories

Corporate Spotlight
Not Yet Available